Drug recall D-0627-2021
Product
1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose vial (NDC 0409-4279-16), packaged in 25 vials per tray (NDC 0409-4279-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.
Reason for recall
Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP
Lots and codes
Lot EG8933, Exp. 08/01/2022
Recall details
- Recalling firm
- PFIZER, INC, Lake Forest, IL
- Quantity
- 139,050 vials
- Distribution
- Nationwide in the USA, Puerto Rico, and Guam
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 3, 2021
- Terminated
- April 4, 2023
Related products
- Lidocaine Hydrochloride – drug information
- NDC 0409-4776 Lidocaine Hydrochloride · Lidocaine Hydrochloride 15 mg/mL · Hospira, Inc.
- NDC 0409-4277 Lidocaine Hydrochloride · Lidocaine Hydrochloride 20 mg/mL · Hospira, Inc.
- NDC 0409-4276 Lidocaine Hydrochloride · Lidocaine Hydrochloride 10 mg/mL · Hospira, Inc.
- NDC 0409-4282 Lidocaine Hydrochloride · Lidocaine Hydrochloride 20 mg/mL · Hospira, Inc.
- NDC 0409-4278 Lidocaine Hydrochloride · Lidocaine Hydrochloride 5 mg/mL · Hospira, Inc.
- NDC 0409-4713 Lidocaine Hydrochloride · Lidocaine Hydrochloride 10 mg/mL · Hospira, Inc.
- NDC 0409-4279 Lidocaine Hydrochloride · Lidocaine Hydrochloride 10 mg/mL · Hospira, Inc.
- NDC 0409-4275 Lidocaine Hydrochloride · Lidocaine Hydrochloride 5 mg/mL · Hospira, Inc.